Literature DB >> 11127655

Malignant transformation of a giant cell tumor 25 years after initial treatment.

Y Mori1, H Tsuchiya, M Karita, A Nonomura, T Nojima, K Tomita.   

Abstract

The current authors report a patient in whom a malignant fibrous histiocytoma developed long after a benign giant cell tumor of bone was removed from the same site. Twenty-five years after a benign giant cell tumor of the lateral condyle of the proximal tibia had been treated by curettage and iliac bone grafting without radiotherapy, a 53-year-old woman noted progressive pain and an enlarging mass in the same area. Radiographs showed osteolytic change, whereas magnetic resonance imaging indicated a tumor arising at the site of the giant cell tumor and extending beyond the bone. Examination of an open biopsy specimen showed a high-grade malignant fibrous histiocytoma with some areas rich in giant cells. After five courses of caffeine assisted intraarterial chemotherapy, the tumor was resected with an adequate margin, and the defect was reconstructed with an implanted prosthesis of corresponding shape. The extensor mechanism of the knee was reinforced using an allograft of fascia from the tensor fascia lata muscle. The resected specimen showed a good histologic response (95% tumor necrosis) to preoperative chemotherapy. Excellent function in the knee has been regained with no evidence of disease recurrence. Caffeine potentiated chemotherapy was effective in minimizing the extent of tumor excision, in this case of high-grade malignant fibrous histiocytoma representing transformation from a benign giant cell tumor.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11127655     DOI: 10.1097/00003086-200012000-00022

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  8 in total

Review 1.  Giant cell tumour of bone: morphological, biological and histogenetical aspects.

Authors:  Mathias Werner
Journal:  Int Orthop       Date:  2006-09-30       Impact factor: 3.075

2.  Treatment and outcome of malignant giant cell tumor in the spine.

Authors:  Huabin Yin; Mo Cheng; Bo Li; Binbin Li; Peng Wang; Tong Meng; Jing Wang; Wang Zhou; Wangjun Yan; Jianru Xiao
Journal:  J Neurooncol       Date:  2015-06-04       Impact factor: 4.130

3.  Comprehensive molecular imaging of malignant transformation of giant cell tumour of bone reveals diverse disease biology.

Authors:  Kalevi Kairemo; Wei-Lien Wang; Vivek Subbiah
Journal:  BMJ Case Rep       Date:  2019-04-23

4.  miR-181c associates with tumor relapse of high grade osteosarcoma.

Authors:  Federica Mori; Andrea Sacconi; Valeria Canu; Federica Ganci; Mariangela Novello; Vincenzo Anelli; Renato Covello; Virginia Ferraresi; Paola Muti; Roberto Biagini; Giovanni Blandino; Sabrina Strano
Journal:  Oncotarget       Date:  2015-06-10

5.  [Giant cell tumor of bone with rapid malignant course].

Authors:  M R Lachat; M Weber; M D Cserhati; H P Honegger; A R von Hochstetter
Journal:  Orthopade       Date:  2004-03       Impact factor: 1.087

Review 6.  A High-grade Sarcoma Arising in a Patient With Recurrent Benign Giant Cell Tumor of the Proximal Tibia While Receiving Treatment With Denosumab.

Authors:  Luis A Aponte-Tinao; Nicolas S Piuzzi; Pablo Roitman; German L Farfalli
Journal:  Clin Orthop Relat Res       Date:  2015-03-11       Impact factor: 4.176

7.  Spontaneous malignant transformation of conventional giant cell tumor.

Authors:  H J Grote; M Braun; T Kalinski; N Pomjanski; W Back; U Bleyl; A Böcking; A Roessner
Journal:  Skeletal Radiol       Date:  2004-01-29       Impact factor: 2.199

8.  Clinicopathological and histological analysis of secondary malignant giant cell tumors of bone without radiotherapy.

Authors:  Eiji Nakata; Hotaka Kawai; Tomohiro Fujiwara; Toshiyuki Kunisada; Hirofumi Inoue; Mashu Futagawa; Haruyoshi Katayama; Takuto Itano; Toshifumi Ozaki
Journal:  Oncol Lett       Date:  2022-07-19       Impact factor: 3.111

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.